Regenerex Pharma (RGPX) Shares Outstanding (Diluted Average) (2010 - 2014)

Regenerex Pharma (RGPX) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $153.0 million in Q4 2014.

• Shares Outstanding (Diluted Average) for Q4 2014 came in at $153.0 million, up 1.77% year-over-year; the trailing twelve-month figure through Nov 2014 was $153.0 million (up 1.77% YoY), and the FY2014 annual result was $153.0 million, up 1.77% from the prior year.
• Shares Outstanding (Diluted Average) held at $153.0 million in Q4 2014 per RGPX's latest filing, from $153.1 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $153.1 million in Q3 2014 and troughed at $98.2 million in Q3 2011.
• A 5-year average of $144.3 million and a median of $149.1 million in 2013 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2011 and 2012: Shares Outstanding (Diluted Average) plunged 30.63% in 2011, then soared 45.98% in 2012.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $141.5 million in 2010, then sank by 30.63% to $98.2 million in 2011, then jumped by 46.1% to $143.5 million in 2012, then advanced by 4.77% to $150.3 million in 2013, then rose by 1.77% to $153.0 million in 2014.
• Business Quant data shows RGPX's Shares Outstanding (Diluted Average) at $153.0 million in Q4 2014, $153.1 million in Q3 2014, and $151.2 million in Q2 2014.